CME Cme Group Inc

  1. Stocks
  2. Financial Services
  3. NASDAQ: CME

Price (delayed)

$242.26

Market cap

$87.78B

P/E Ratio

20.53

Dividend/share

$11.25

EPS

$11.8

Enterprise value

$253.85B

?
Relative Growth: Rel. Growth: 85
Relative Strength: Rel. Strength: 23
Relative Valuation: Rel. Valuation: 44
Relative Profitability: Rel. Profitability: 92

CME Group Inc. is a global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, ...

Highlights
CME's P/E is 21% below its 5-year quarterly average of 26.0 and 20% below its last 4 quarters average of 25.6
The company's net income rose by 18% YoY and by 5% QoQ
The debt has grown by 36% year-on-year and by 3.3% since the previous quarter
The equity has declined by 7% since the previous quarter
Sector: Financial Services
Industry: Financial Data & Stock Exchanges
Website: https://www.cmegroup.com/
Peers: MSCI ICE CBOE NDAQ

Key stats

What are the main financial stats of CME

CME stock price

How has the Cme Group stock price performed over time
Intraday
-1.2%
1 week
-7.39%
1 month
-16.81%
1 year
-11.15%
YTD
-11.29%
QTD
-17.98%

Financial performance

How have Cme Group's revenue and profit performed over time
Revenue
$6.76B
Gross profit
$6.76B
Operating income
$4.43B
Net income
$4.23B
Gross margin
100%
Net margin
62.6%
The company's net income rose by 18% YoY and by 5% QoQ
The net margin has grown by 9% year-on-year
The operating income is up by 9% YoY and by 4.8% QoQ
CME's revenue is up by 8% year-on-year and by 3.6% since the previous quarter

Price vs fundamentals

How does CME's price correlate with its fundamentals

Growth

What is Cme Group's growth rate over time

Valuation

What is Cme Group stock price valuation
CME P/E details
P/E
20.53
P/B
3.26
P/S
12.88
EV/EBIT
44.28
EV/EBITDA
41.86
EV/Sales
37.56
CME's P/E is 21% below its 5-year quarterly average of 26.0 and 20% below its last 4 quarters average of 25.6
The EPS is up by 18% year-on-year and by 6% since the previous quarter
CME's price to book (P/B) is 12% higher than its 5-year quarterly average of 2.9 but 9% lower than its last 4 quarters average of 3.6
The equity has declined by 7% since the previous quarter
The P/S is 16% lower than the last 4 quarters average of 15.3 and 11% lower than the 5-year quarterly average of 14.5
CME's revenue is up by 8% year-on-year and by 3.6% since the previous quarter

Efficiency

How efficient is Cme Group business performance
The ROIC has contracted by 18% YoY
Cme Group's return on equity has increased by 16% YoY and by 6% QoQ
Cme Group's return on assets has decreased by 15% YoY
The return on sales is up by 11% year-on-year

Dividends

What is CME's dividend history
Dividend details
DPS
$11.25
Dividend yield
4.64%
Payout ratio
95.3%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Cme Group financials performed over time
Cme Group's total assets is 15% more than its total liabilities
Cme Group's total liabilities has increased by 34% YoY and by 3.3% QoQ
Cme Group's total assets has increased by 28% YoY
The debt to equity has grown by 38% YoY and by 11% from the previous quarter
The debt has grown by 36% year-on-year and by 3.3% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.